Infectious Disease Control
FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID
* FB2001 (Bofutrelvir) is a Coronavirus Mpro inhibitor, which exhibited potent anti-SARS-CoV-2 activityin vitro and in vivo * Phase 1 results show FB2001 to be generally safe and well tolerated. No significant difference was observed between Chinese and American populations. Single-agent anti...
2022-08-09 00:00
3835
Catalytic Investment to Improve Community Health Care for Millions Across Africa
The Global Fund collaborates with the Johnson & Johnson Foundation and the Skoll Foundation to Launch the Africa Frontline First Catalytic Fund * Private sector investments to the Global Fund's Africa Frontline First Catalytic Fund from the Johnson & Johnson Foundation and the Skoll Foundation ...
2022-08-08 19:07
2451
ECOLAB NAMES GREGORY LUKASIK SENIOR VICE PRESIDENT AND MARKET HEAD FOR SOUTHEAST ASIA
SINGAPORE, Aug. 5, 2022 /PRNewswire/ -- Ecolab Inc., the global leader in
water, hygiene and infection prevention solutions and services, namedGregory
Lukasik
2022-08-05 09:00
9495
Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya
HAMBURG, Germany, Aug. 3, 2022 /PRNewswire/ -- Vela Diagnostics has announced its appointment by the National Public Health Laboratory ofKenya (NPHL) as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund. The NPHL operates under Kenya's Ministry of Health and plays...
2022-08-03 14:00
2638
Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS) in collaboration with the Amsterdam UMC and Danish Rigshospitalet
GOES, Netherlands, Aug. 2, 2022 /PRNewswire/ -- In the worldwide effort to control monkeypox, a novel and fast typing method to trace monkeypox virus strains was developed by Dutch company Molecular Biology Systems (MBS) in collaboration with the department of Medical Microbiology & Infectious Di...
2022-08-02 08:00
2962
PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinkin...
2022-08-01 09:03
3481
Global Fund Reports Significant Progress in Breaking Down Human Rights-Related Barriers to HIV and TB Services
MONTREAL, Aug. 1, 2022 /PRNewswire/ -- A new report
2022-08-01 08:59
2333
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants
Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously demonstrated with all variants of concern to date The amubarvimab/romlusevimab combination is commercially available in China and is under rev...
2022-07-27 07:00
4166
Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan
* Nuvaxovid™ is the first protein-based COVID-19 vaccine approved for use in adolescents inJapan GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious d...
2022-07-26 20:05
3069
Vaccines alone aren't enough to combat AMR, claims new WHO report
The Global Hygiene Council (GHC) calls for the use of hygiene practices, such
as handwashing, alongside vaccinations to prevent the spread of infectious
diseases and reduce the impact of antimicrobial resistance (AMR).
LONDON, July 23, 2022 /PRNewswire/ -- A recent report
2022-07-23 00:30
9241
VIRALEZE™ Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral Exposure
MELBOURNE, Australia, July 20, 2022 /PRNewswire/ -- Starpharma's broad-spectrum VIRALEZE™ nasal spray has shown protection against infection with the highly transmissible SARS-CoV-2 Omicron variant in a stringent viral challenge model. VIRALEZE™ is a broad-spectrum barrier nasal spray, developed ...
2022-07-20 17:45
2549
U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older
* Recommendation follows U.S. FDA Emergency Use Authorization for the Novavax COVID-19 Vaccine, Adjuvanted as a two-dose primary series * FDA has determined that first vaccine lot has met all release specifications and is acceptable for use underEmergency Use Authorization * Novavax expects ...
2022-07-20 05:46
3311
Seegene launches world's first In-life PCR campaign in Vietnam
* Test center LabHouse and ride-hailing service Grab to start PCR testing for Grab drivers in August * Seegene to provide Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay to simultaneously detect COVID-19, flu, cold * Testing to begin with drivers in Ho Chi Minh, Hanoi and will later be expanded to ...
2022-07-19 18:43
2412
Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group to Advance the Commercialization of Long-acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The amubarvimab/romlusevimab combination is the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, evaluated through a rand...
2022-07-19 12:34
4761
Zymo Research's DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples
IRVINE, Calif., July 15, 2022 /PRNewswire/ -- Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg,Germany, demonstrated data showing their DNA/RNA Shield™ Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus isolate...
2022-07-15 06:42
4525
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over
* Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. * Immunizations with the Novavax COVID-19 Vaccine, Adjuvanted as a primary series will begin upon product release and once a policy recommendation from the CDC is received GAITHERSBURG, Md., July 14, 2022 /P...
2022-07-14 06:06
4048
Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal
MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announced thatThe Lancet Regional Health Southeast Asia (TLRHSEA) – peer reviewed, high...
2022-07-13 20:06
3764
Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer
Strategic executive hire adds to Company's global leadership team and positions
the Company for continued growth
DURHAM, N.C.and BEIJING, July 13, 2022 /PRNewswire/ -- Brii Biosciences
Limited
2022-07-13 19:00
3822
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
* Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md. ,July 11, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-gene...
2022-07-11 20:10
4500
iGene Laboratory launches Monkeypox PCR test for the South East Asian region.
SINGAPORE, July 8, 2022 /PRNewswire/ -- iGene Laboratory, the molecular
diagnostics laboratory subsidiary of INEX Innovate Pte Ltd, announces the
launch of its research-use-only (RUO) polymerase chain reaction (PCR) Monkeypox
test in response to the recent outbreak of the virus.
2022-07-08 12:25
3851
Week's Top Stories
Most Reposted
Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 313 media titles]
2026-05-06 12:00
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 295 media titles]
2026-05-12 10:15
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 293 media titles]
2026-05-11 16:20
Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 288 media titles]
2026-05-12 10:00Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 282 media titles]
2026-05-12 14:00
Most Read
Amadeus delivers solid Q1 2026 growth, and maintains commercial momentum
2026-05-08 18:30
7909
LightInTheBox to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
2026-05-06 20:00
7322
Massimo Group Launches Sentinel 770 HVAC as Part of Sentinel Product Line Targeting Approximately US$10 Million in 2026 Revenue
2026-05-06 21:20
7225
NYSE Content Update: HawkEye 360 to Start Trading after its $416 Million IPO
2026-05-07 21:35
6662
Pony.ai Labor Day Holiday Robotaxi Paid Orders Surge More Than Sixfold
2026-05-08 20:00
6470